These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10767052)

  • 1. Therapeutic apheresis in neurological disorders.
    Weinstein R
    J Clin Apher; 2000; 15(1-2):74-128. PubMed ID: 10767052
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic indications for therapeutic plasma exchange: 2011 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2012; 27(3):138-45. PubMed ID: 22522566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic plasma exchange for neuroimmunological disorders].
    Shibuya N
    No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
    [No Abstract]   [Full Text] [Related]  

  • 5. Current treatment of neuromuscular diseases.
    Kokontis L; Gutmann L
    Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.
    Mahalati K; Dawson RB; Collins JO; Mayer RF
    J Clin Apher; 1999; 14(1):1-8. PubMed ID: 10355656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A period of trial in American apheresis medicine.
    Weinstein R
    Transfus Apher Sci; 2001 Oct; 25(2):89-91. PubMed ID: 11761279
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune modulation of paraneoplastic neurologic disorders.
    Graus F; Delattre JY
    Clin Neurol Neurosurg; 1995 Feb; 97(1):112-6. PubMed ID: 7788966
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of therapeutic plasma exchange for pediatric neurological diseases.
    Ipe TS; Meyer EK; Sanford KW; Joshi SK; Wong ECC; Raval JS
    J Clin Apher; 2021 Feb; 36(1):161-176. PubMed ID: 33063869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in neurology.
    Uldry PA; Steck AJ
    Curr Stud Hematol Blood Transfus; 1990; (57):167-83. PubMed ID: 2272200
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin use for neurologic diseases.
    Koski CL; Patterson JV
    J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using immunoglobulins in muscular disease treatment.
    Pul R; Stangel M
    Expert Opin Biol Ther; 2008 Aug; 8(8):1143-50. PubMed ID: 18613765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour therapy in paraneoplastic neurological disease.
    Grisold W; Drlicek M; Liszka-Setinek U; Wondrusch E
    Clin Neurol Neurosurg; 1995 Feb; 97(1):106-11. PubMed ID: 7788965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.
    ; Jacob S; Muppidi S; Guidon A; Guptill J; Hehir M; Howard JF; Illa I; Mantegazza R; Murai H; Utsugisawa K; Vissing J; Wiendl H; Nowak RJ
    J Neurol Sci; 2020 May; 412():116803. PubMed ID: 32247193
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.